康柏西普单次玻璃体腔注射治疗视网膜静脉阻塞伴黄斑水肿  

The efficiency of conbercept intravitreal injection for treating retinal vein occlusion complicated with macular edema

作　　者：何勤[1] 王林[1] 柯根杰[1] 顾永昊[1] 

机构地区：[1]安徽医科大学附属安徽省立医院眼科,230001

出　　处：《实用防盲技术》2016年第2期69-71,共3页Journal of Practical Preventing Blind

摘　　要：目的观察康柏西普眼用注射液单次玻璃体腔注射治疗视网膜静脉阻塞伴有黄斑水肿的短期疗效。方法观察自2014年12月至2015年9月期间在安徽省立医院诊断为视网膜静脉阻塞合并黄斑水肿病例14例(14只眼)。诊断明确后行玻璃体腔注射0.05ml康柏西普眼用注射液,治疗后随访4周,复诊观察最佳矫正视力、黄斑中心凹厚度。结果康柏西普治玻璃体腔单次注射后4周复诊最佳矫正视力与治疗前相比,视力提高(t=8.23,P<0.05),黄斑中心凹厚度降低(t=11.24,P<0.05),差异均有统计学意义。结论康柏西普单次玻璃体腔注射治疗视网膜静脉阻塞伴有黄斑水肿短期内安全有效。Objetive To evaluate the efficiency of conbercept intravitreal injection in patients with macular edema caused by retinal vein occlusion（RVO）. Methods 14 eyes of 14 patients with macular edema caused by RVO were included. The patients were treated with 0.05 ml intravitreal injection of conbercept just once and followed up for 4 weeks. Best corrected visual acuity and central subfield thickness were analyzed. Results Four weeks after the administration of conbercept, we found in our patients that best corrected visual acuity improved（t=8.23,P 0.05）and central subfield thickness decreased（t=11.24,P 0.05）. Conclusion Conbercept intravitreal injection is efficient for treating RVO complicated with macular edema.

关 键 词：康柏西普 视网膜静脉阻塞 黄斑水肿 

分 类 号：R774[医药卫生—眼科]